These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12762316)

  • 1. [Drugs against urinary incontinence].
    Schiøtz H
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):840; reply 840. PubMed ID: 12762316
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticholinergic drugs for overactive bladder.
    Kripke C
    Am Fam Physician; 2006 Jan; 73(1):66. PubMed ID: 16417066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of female urinary incontinence: an overview].
    Palomba S; Falbo A; Damiano R; Zullo F
    Minerva Ginecol; 2007 Oct; 59(5):543-8. PubMed ID: 17912180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy in urinary incontinence and/or bladder emptying problems].
    Møller LA; Abel I; Thyssen H; Sander P; Mouritsen L; Lose G; Sørensen C; Philipsen J; Ottesen M; Rasmussen FA; Topp M; Larsen J; Gimbel H
    Ugeskr Laeger; 2006 Jun; 168(26-32):2580-1; author reply 2581. PubMed ID: 16824423
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary incontinence. Know your drug options.
    Mayo Clin Health Lett; 2005 Nov; 23(11):6. PubMed ID: 16419295
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic therapy for urinary incontinence.
    Ghoniem GM
    Urol Nurs; 1996 Jun; 16(2):55-8. PubMed ID: 8826154
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic strategy and impact of new treatments].
    Haab F
    Ann Urol (Paris); 2005 Dec; 39 Suppl 6():S188-91. PubMed ID: 16440495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticholinergic treatment of overactive bladder. A costly treatment with doubtful clinical effect?].
    Møller LA; Lose G
    Ugeskr Laeger; 2003 Nov; 165(47):4552-3. PubMed ID: 14677238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary incontinence. When the bladder does not cooperate anymore].
    Koczorek M
    MMW Fortschr Med; 2002 Nov; 144(48):14. PubMed ID: 12532538
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Lazzeri M
    Eur Urol; 2009 Mar; 55(3):737-8. PubMed ID: 18502027
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary incontinence. Various forms and therapeutic consequences].
    Löhmer H; Melchior H
    Med Monatsschr Pharm; 1996 Nov; 19(11):320-9. PubMed ID: 9036268
    [No Abstract]   [Full Text] [Related]  

  • 12. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population.
    Sakakibara R; Uchiyama T; Yamanishi T; Kishi M
    Int J Urol; 2008 Sep; 15(9):778-88. PubMed ID: 18643858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
    Ellsworth P
    J Urol; 2003 Sep; 170(3):928; author reply 928. PubMed ID: 12913741
    [No Abstract]   [Full Text] [Related]  

  • 14. Overactive bladder: a clinical entity or a marketing hype?
    Madersbacher H
    Eur Urol; 2005 Mar; 47(3):273-6. PubMed ID: 15716186
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis.
    Ferrara P; Marrone G; Mastrangelo A; Nicoletti A; Emmanuele V; Fasano A
    Scand J Urol Nephrol; 2007; 41(3):218-22. PubMed ID: 17469031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of overactive bladder (OBA) with anti-cholinergic drugs and the risk of glaucoma.
    Eskandar OS; Eckford SD; Whittaker KW
    J Obstet Gynaecol; 2005 Jul; 25(5):419-21. PubMed ID: 16183571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
    Gill SS; Mamdani M; Naglie G; Streiner DL; Bronskill SE; Kopp A; Shulman KI; Lee PE; Rochon PA
    Arch Intern Med; 2005 Apr; 165(7):808-13. PubMed ID: 15824303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR; Te AE
    BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent revisions to the State Operations Manual: implications for the management of urinary incontinence.
    Oliff L
    Director; 2007; 15(2):12-6. PubMed ID: 19343902
    [No Abstract]   [Full Text] [Related]  

  • 20. Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives.
    Salvatore S; Soligo M; Proietti F; Citterio S; Artibani W; Milani R
    Eur J Obstet Gynecol Reprod Biol; 2005 Jun; 120(2):129-33. PubMed ID: 15925039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.